A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781
NCT03131141
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BC-3781
Sponsor
Nabriva Therapeutics AG
Collaborators
[object Object]